Recent Advances in Biological Activity, New Formulations and Prodrugs of Ferulic Acid

by Monika Stompor-Gorący, Maciej Machaczka
Published 2021-11-01

Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent

by Monika Stompor-Gorący, Agata Bajek-Bil, Maciej Machaczka
Published 2021-06-01

Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review

by Małgorzata Kałużna, Isabella Trzeciak, Katarzyna Ziemnicka, Maciej Machaczka, Marek Ruchała
Published 2019-12-01

Neurocognitive profile of adults with the Norrbottnian type of Gaucher disease

by Panagiota Tsitsi, Ioanna Markaki, Josefine Waldthaler, Maciej Machaczka, Per Svenningsson
Published 2022-01-01

Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3

by Josefine Blume, Stanislav Beniaminov, Cecilia Kämpe Björkvall, Maciej Machaczka, Per Svenningsson
Published 2017-06-01

Development of classical Hodgkin’s lymphoma in an adult with biallelic STXBP2 mutations

by Maciej Machaczka, Monika Klimkowska, Samuel C.C. Chiang, Marie Meeths, Martha-Lena Müller, Britt Gustafsson, Jan-Inge Henter, Yenan T. Bryceson
Published 2013-05-01

Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease

by Aimee Donald, Cecilia Kämpe Björkvall, Ashok Vellodi, GAUCHERITE Consortium, Timothy M. Cox, Derralyn Hughes, Simon A. Jones, Robert Wynn, Maciej Machaczka
Published 2022-06-01